Tandem Diabetes Care TNDM Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.01B+7.9% | $940.2M+25.7% | $747.72M-6.7% | $801.22M+14.0% | ||
| $468.72M+4.0% | $450.63M+18.6% | $380.03M-2.1% | $388.23M+18.9% | ||
| $546.01M+11.5% | $489.57M+33.1% | $367.69M-11.0% | $412.99M+9.8% | ||
| 53.8%+1.7pp | 52.1%+2.9pp | 49.2%-2.4pp | 51.5%-2.0pp | ||
| $193.11M-2.9% | $198.88M+17.2% | $169.67M+22.0% | $139.11M+51.1% | ||
| $444.99M+14.2% | $389.82M+10.6% | $352.5M+5.0% | $335.68M+28.4% | ||
| $733.27M+24.6% | $588.7M-2.0% | $600.92M+18.8% | $505.83M+43.1% | ||
| $733.27M+24.6% | $588.7M-2.0% | $600.92M+18.8% | $505.83M+43.1% | ||
| -$187.26M-88.9% | -$99.13M+57.5% | -$233.23M-151% | -$92.85M-510% | ||
| -18.5%-7.9pp | -10.5%+20.6pp | -31.2%-19.6pp | -11.6%-14.8pp | ||
| $7.91M+6.6% | $7.42M-25.0% | $9.88M+59.2% | $6.21M+2.8% | ||
| -$13.02M-279% | $7.26M-44.1% | $12.98M— | —— | ||
| -$14.19M-591% | -$2.05M— | $0— | $0— | ||
| -$204.95M-123% | -$91.89M+58.3% | -$220.25M-137% | -$92.85M-684% | ||
| $4.44M— | —— | —— | —— | ||
| -$204.71M-113% | -$96.03M+56.9% | -$222.61M-135% | -$94.59M-708% | ||
| -20.2%-10.0pp | -10.2%+19.6pp | -29.8%-18.0pp | -11.8%-14.0pp | ||
| -$3.07-110% | -$1.46+57.6% | -$3.44-132% | -$1.48-743% | ||
| -$3.07-110% | -$1.46+57.6% | -$3.44-134% | -$1.47-713% | ||
| 269.1M+2.7% | 262M+0.8% | 259.9M+1.3% | 256.6M-0.9% | ||
| 269.1M+2.8% | 261.8M+0.7% | 259.9M+1.3% | 256.6M+1.8% | ||
| -$197.17M-98.5% | -$99.34M+54.7% | -$219.43M-129% | -$95.8M-750% | ||
| $9.09M-49.5% | $17.99M-21.3% | $22.86M— | —— | ||
| $566K+282% | -$311K-109% | $3.61M— | —— | ||
| -$312K— | $0— | $0— | —— | ||
| -$13.02M-279% | $7.26M-44.1% | $12.98M— | —— | ||
| $75.22M— | $0-100% | $78.75M+154% | $31.04M— | ||
| $193.11M-2.9% | $198.88M+17.2% | $169.67M+22.0% | $139.11M— | ||
| $1.01B+7.9% | $940.2M+25.7% | $747.72M-6.7% | $801.22M+14.0% | ||
| -$187.26M-88.9% | -$99.13M+57.5% | -$233.23M-151% | -$92.85M-510% | ||
| -$169.59M-106% | -$82.52M+62.1% | -$217.52M-177% | -$78.52M-315% | ||
| -$169.59M-106% | -$82.52M+62.1% | -$217.52M-177% | -$78.52M-315% | ||
| -16.7%-7.9pp | -8.8%+20.3pp | -29.1%-19.3pp | -9.8%-15.0pp | ||
| -$187.26M-88.9% | -$99.13M+57.5% | -$233.23M-151% | -$92.85M-510% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Tandem Diabetes Care's revenue?
- Tandem Diabetes Care (TNDM) generated $1.0B in revenue over the trailing twelve months, up 4.5% year over year.
- Is Tandem Diabetes Care profitable?
- Tandem Diabetes Care is not currently profitable: it reported a net loss of $94.5M over the trailing twelve months, a -9.2% net margin.
- What are Tandem Diabetes Care's profit margins?
- Gross margin is 54.9% and operating margin is -8.2%, with a -9.2% net margin.
- What is Tandem Diabetes Care's earnings per share?
- Tandem Diabetes Care's diluted EPS over the trailing twelve months is $-1.40.
- Where does Tandem Diabetes Care's income statement data come from?
- Every line is extracted from Tandem Diabetes Care's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
